For the establishment of the PD-L1 assay on CETCs we tested different cancer cell lines (MCF-7, Sk-Br-3, SW620 and H820) and different clones of PD-L1 antibodies (clone 29E.2A3, clone 130021 and clone MIH1). Here, CD274 is linked to cancer.